Current News

HDMA Supports New Legislation to Encourage Prescription Drug Monitoring Program Interoperability

Cardinal Health Receives HDMA Distribution Management Award

HDMA Applauds Passage of SAFE DOSES Act, Counterfeit Drug Penalty Bill

HDMA Testifies Before House Energy and Commerce Subcommittee on Health

HDMA's John M. Gray Testifies Before Congress on Prescription Drug Diversion

 

Visit HDMA News Center >


print page

 


 

 

Press Release
Contact:
Jeff Van Ness, HDMA, (703) 885-0216
jvanness@hdmanet.org

HDMA JOINS THE FDA COUNTERFEIT ALERT NETWORK

ARLINGTON, VA — May 12, 2006 — As part of ongoing efforts to fight the threat of counterfeit drugs to the U.S. medicine supply, the Healthcare Distribution Management Association (HDMA) joined the Food and Drug Administration’s (FDA) Counterfeit Alert Network.

The Counterfeit Alert Network is designed to inform consumers, pharmacists, healthcare professionals, distributors and other healthcare organizations of counterfeit drug incidents, and provides education on ways to identify and prevent counterfeits from entering the U.S. medicine supply. 

“HDMA members serve as the central link in a sophisticated supply chain. As such, we have a responsibility to work closely with government, manufacturers, providers and law enforcement to safeguard patient health,” said HDMA President and CEO John M. Gray. “Patient safety and supply chain security is our members’ greatest concern, and we strongly support efforts to further secure the U.S. healthcare system.”

As a partner in the Counterfeit Alert Network, HDMA will distribute time-sensitive FDA messages and information on specific counterfeit incidents to member distribution companies.  HDMA also will provide educational messages about counterfeit drugs, as well as information needed to recognize and report suspect or counterfeit drug products to FDA. 

Joining the Counterfeit Alert Network is the latest in a series of measures led by HDMA to fight the threat of counterfeit drugs.  HDMA has and will continue to petition states across the United States to crack down on criminals who seek to obtain drug distribution licenses, and has been leading the call for stricter licensing standards, stronger regulations, greater enforcement, tougher criminal penalties and best business practices to help secure the nation’s medicine supply. HDMA is also a strong advocate for current and emerging anti-counterfeiting technologies, such as EPC/RFID.


About HDMA

The Healthcare Distribution Management Association (HDMA) is the national association representing primary, full-service healthcare distributors. Each business day, the member companies of HDMA are responsible for ensuring that more than eight million prescription medicines and healthcare products are safely delivered to 145,000 pharmacies, hospitals, nursing homes, physician offices, clinics, government and other providers in all 50 states. This essential public health function is provided with tremendous efficiency, saving the nation’s healthcare system nearly $32 billion each year. HDMA and its members are the vital link in the healthcare system, working daily to provide value, remove costs and develop innovative solutions to deliver care safely and effectively.
 
© Copyright Healthcare Distribution Management Association.
All rights reserved.
HDMA: M | C | D
Do you have suggestions
for our site?
URL: